TELA Bio, Inc.TELANASDAQ

Revenue (LTM)

$69M

+18.6% YoY

Net Income (LTM)

$-38M

+18.9% YoY

Free Cash Flow

$-43M

Revenue CAGR (5Y)

+35.0%

Marginsimproving

FCF($0.0B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	18	29↑61.8%	41↑40.6%	58↑41.1%	69↑18.6%
Gross Profit	11	19↑67.5%	27↑43.8%	40↑48.3%	46↑15.9%
Operating Income	-25	-29↓16.5%	-39↓32.4%	-44↓13.0%	-34↑22.6%
Net Income	-29	-33↓15.6%	-44↓33.1%	-47↓5.3%	-38↑18.9%
EBITDA	-25	-29↓18.0%	-39↓34.0%	-41↓4.0%	-32↑22.0%
EPS Diluted	-2.23	-2.30↓3.1%	-2.73↓18.7%	-2.04↑25.3%	-1.33↑34.8%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	74	44↓40.9%	42↓4.4%	47↑11.2%	53↑12.7%
Total Current Assets	83	59↓29.0%	62↑5.7%	72↑14.9%	78↑8.8%
Total Assets	86	63↓27.7%	68↑8.5%	78↑15.0%	87↑11.9%
Total Current Liabilities	7	11↑60.1%	12↑17.3%	17↑36.8%	16↓8.1%
Total Liabilities	37	42↑13.4%	54↑26.2%	59↑10.5%	59↓0.5%
Total Equity	49	20↓59.0%	14↓28.8%	19↑32.0%	28↑50.7%
Total Debt	31	31↑2.2%	41↑31.6%	43↑3.2%	43↑0.7%
Net Debt	-44	-12↑71.4%	-1↑95.5%	-4↓604.1%	-10↓142.5%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-24	-30↓24.4%	-41↓33.9%	-41↓0.3%	-42↓1.8%
Capital Expenditure	-0	-1↓275.4%	-2↓198.6%	-1↑67.4%	-1↓61.9%
Free Cash Flow	-25	-31↓26.1%	-43↓37.2%	-41↑2.7%	-43↓2.7%
Stock-Based Comp	2	4↑77.9%	4↑9.0%	5↑26.1%	4↓13.3%
Net Change in Cash	29	-30↓204.7%	-2↑93.7%	5↑360.2%	6↑19.4%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance